Alpha Lipoic Acid (ALA) for Diabetic Neuropathy

Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4 years in the NATHAN 1 trial Dan Ziegler, Phillip A. Low, Roy Freeman, Hans Tritschler, Aaron I.

Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4 years in the NATHAN 1 trial Dan Ziegler, Phillip A. Low, Roy Freeman, Hans Tritschler, Aaron I.

Taken from:
Alpha Lipoic Acid (ALA) for Diabetic Neuropathy

Related posts:

  1. Exploring The Potential Of Alpha Lipoic Acid For Diabetic Neuropathy
  2. The emerging role of alpha-lipoic acid for diabetic neuropathy
  3. Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy
  4. Pain Management in Patients with Diabetic Nephropathy: The Emerging Role of {alpha}-Lipoic Acid
  5. The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy
  6. Can Combined Electrochemical Treatment Have An Impact For Diabetic Peripheral Neuropathy?
  7. Should Patients With Diabetic Peripheral Neuropathy Do Weightbearing Exercise?
  8. A Closer Look At An Emerging Supplement For Diabetic Peripheral Neuropathy
  9. Current And Emerging Insights On Treating Diabetic Peripheral Neuropathy
  10. Tarsal tunnel syndrome in diabetic neuropathy